163 related articles for article (PubMed ID: 24482023)
41. High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis.
Iwamoto T; Dorschner JM; Selvaraj S; Mezzano V; Jensen MA; Vsetecka D; Amin S; Makol A; Osborn T; Moder K; Chowdhary VR; Izmirly P; Belmont HM; Clancy RM; Buyon JP; Wu M; Loomis CA; Niewold TB
J Rheumatol; 2022 Apr; 49(4):388-397. PubMed ID: 34782453
[TBL] [Abstract][Full Text] [Related]
42. Increased apoptosis and expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV.
Cui JH; Qiao Q; Guo Y; Zhang YQ; Cheng H; He FR; Zhang J
J Nephrol; 2012; 25(2):255-61. PubMed ID: 21725926
[TBL] [Abstract][Full Text] [Related]
43. Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus.
Min DJ; Cho ML; Cho CS; Min SY; Kim WU; Yang SY; Min JK; Hong YS; Lee SH; Park SH; Kim HY
Scand J Rheumatol; 2001; 30(3):159-63. PubMed ID: 11469526
[TBL] [Abstract][Full Text] [Related]
44. YY1 alleviates lupus nephritis-induced renal injury by reducing the Th17/Treg cell ratio via the IFN-γ/Fra2 axis.
Wang B; Jiang X; Li Y; Xu H; Ying B; Qiu J; Huang Z; Shao X
Lab Invest; 2022 Aug; 102(8):872-884. PubMed ID: 35361881
[TBL] [Abstract][Full Text] [Related]
45. Macrophage subpopulations in pediatric patients with lupus nephritis and other inflammatory diseases affecting the kidney.
Sandersfeld M; Büttner-Herold M; Ferrazzi F; Amann K; Benz K; Daniel C
Arthritis Res Ther; 2024 Feb; 26(1):46. PubMed ID: 38331818
[TBL] [Abstract][Full Text] [Related]
46. Lipocalin-2 Exacerbates Lupus Nephritis by Promoting Th1 Cell Differentiation.
Chen W; Li W; Zhang Z; Tang X; Wu S; Yao G; Li K; Wang D; Xu Y; Feng R; Duan X; Fan X; Lu L; Chen W; Li C; Sun L
J Am Soc Nephrol; 2020 Oct; 31(10):2263-2277. PubMed ID: 32646856
[TBL] [Abstract][Full Text] [Related]
47. Association Between IL-17A, FOXP3, and CTLA4 Genes Expression and Severity of Lupus Nephritis.
Zahiri L; Malekmakan L; Masjedi F; Habibagahi Z; Habibagahi M
Iran J Kidney Dis; 2022 Jan; 1(1):13-23. PubMed ID: 35271496
[TBL] [Abstract][Full Text] [Related]
48. Intrarenal cytokine gene expression in lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Lai KB; Li PK; Szeto CC
Ann Rheum Dis; 2007 Jul; 66(7):886-92. PubMed ID: 17324967
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
50. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L; Ordi-Ros J; Balada E; Segarra-Medrano A; Majó-Masferrer J; Labrador-Horrillo M; Vilardell-Tarrés M
Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
[TBL] [Abstract][Full Text] [Related]
51. Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations.
Mavragani CP; Kirou KA; Seshan SV; Crow MK
Rheumatology (Oxford); 2023 Jul; 62(7):2534-2538. PubMed ID: 36355567
[TBL] [Abstract][Full Text] [Related]
52. Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis.
Wright RD; Beresford MW
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1683-F1694. PubMed ID: 30207171
[TBL] [Abstract][Full Text] [Related]
53. Paeoniflorin ameliorates murine lupus nephritis by increasing CD4
Liang CL; Lu W; Qiu F; Li D; Liu H; Zheng F; Zhang Q; Chen Y; Lu C; Li B; Dai Z
Biochem Pharmacol; 2021 Mar; 185():114434. PubMed ID: 33513343
[TBL] [Abstract][Full Text] [Related]
54. Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients.
Dedong H; Feiyan Z; Jie S; Xiaowei L; Shaoyang W
Immunol Lett; 2019 Jun; 210():33-39. PubMed ID: 31004679
[TBL] [Abstract][Full Text] [Related]
55. Value of Foxp3 expressing T-regulatory cells in renal tissue in lupus nephritis; an immunohistochemical study.
Shakweer MM; Behairy M; Elhefnawy NG; Elsaid TW
J Nephropathol; 2016 Jul; 5(3):105-10. PubMed ID: 27540538
[TBL] [Abstract][Full Text] [Related]
56. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
[TBL] [Abstract][Full Text] [Related]
57. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
58. Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis.
Zickert A; Janković MR; Malmström V; Chemin K; Gunnarsson I
Clin Rheumatol; 2023 Oct; 42(10):2889-2895. PubMed ID: 37368057
[TBL] [Abstract][Full Text] [Related]
59. Significant reduction in the expression of interleukins-17A, 22 and 23A, forkhead box p3 and interferon gamma delineates lichen planus pigmentosus from lichen planus.
Kumaran MS; Bishnoi A; Srivastava N; Tekumalla S; Vinay K; Bhatia A; Parsad D
Arch Dermatol Res; 2019 Sep; 311(7):519-527. PubMed ID: 31089878
[TBL] [Abstract][Full Text] [Related]
60. Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes.
Tiittanen M; Westerholm-Ormio M; Verkasalo M; Savilahti E; Vaarala O
Clin Exp Immunol; 2008 Jun; 152(3):498-507. PubMed ID: 18435801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
